You are viewing the site in preview mode

Skip to main content

Sway frequencies may predict postural instability in Parkinson’s disease: a novel convolutional neural network approach

Abstract

Background

Postural instability greatly reduces quality of life in people with Parkinson’s disease (PD). Early and objective detection of postural impairments is crucial to facilitate interventions. Our aim was to use a convolutional neural network (CNN) to differentiate people with early to mid-stage PD from healthy age-matched individuals based on spectrogram images obtained from their body sway. We hypothesized the time–frequency content of body sway to be predictive of PD, even when impairments are not yet clinically apparent.

Methods

18 people with idiopathic PD and 15 healthy controls (HC) participated in the study. We tracked participants’ center of pressure (COP) using a Wii Balance Board and their full-body motion using a Microsoft Kinect, out of which we calculated the trajectory of their center of mass (COM). We used 30 s-snippets of motion data from which we acquired wavelet-based time–frequency spectrograms that were fed into a custom-built CNN as labeled images. We used binary classification to have the network differentiate between individuals with PD and controls (n = 15, respectively).

Results

Classification performance was best when the medio-lateral motion of the COM was considered. Here, our network reached a predictive accuracy, sensitivity, specificity, precision and F1-score of 100%, respectively, with a receiver operating characteristic area under the curve of 1.0. Moreover, an explainable AI approach revealed high frequencies in the postural sway data to be most distinct between both groups.

Conclusion

Heeding our small and heterogeneous sample, our findings suggest a CNN classifier based on cost-effective and conveniently obtainable posturographic data to be a promising approach to detect postural impairments in early to mid-stage PD and to gain novel insight into the subtle characteristics of impairments at this stage of the disease.

Background

Parkinson’s disease (PD) currently affects around 1% of the population over 60 [1, 2] and is predicted to affect around 3% of the world population over 65 by 2030 [3]. Postural instability is considered one of the most disabling features of PD and at later stages increases the risk of falls and significantly reduces quality of life [4,5,6,7,8,9,10].

The gold standard to measure postural instability in clinical settings consists of the Movement Disorder Society Unified Parkinson’s Disease Rating Scale (MDS-UPDRS) [11,12,13] and the Hoehn and Yahr scale [14], performed by clinicians. Even though scales like the MDS-UPDRS score have been attested a good test–retest reliability [11], most clinical balance ratings remain (semi-)subjective, have been shown to be incapable of detecting mild changes [15], and often show poor sensitivity and inconsistency between trials [16, 17]. In addition, motor symptoms visible to a clinician during these tests typically occur at later stages of the disease, while it has been suggested that postural impairments might already be present in the early motor phase and that they might bear the potential as a pre-diagnostic tool to detect the disease [18,19,20,21]. While state-of-the-art symptomatic treatments with levodopa or deep brain stimulation (DBS) may not help postural stability [22,23,24,25], objective detection of subtle balance impairments might allow for timely countermeasures, as there is evidence for positive effects of exercise and specific balance training on postural control [26].

Hence, there is a strong need for objective and easy to obtain measures of postural control to assist clinical testing of PD [3, 27]. Many studies have been trying to find objective markers of postural sway during quiet stance that distinguish individuals with PD from healthy controls (HC) [28,29,30,31]. Most of these studies tried to obtain these markers based on traditional spatiotemporal sway parameters such as sway amplitude, path length, area, and velocity, but some have also explored frequency domain measures like the centroidal frequency or frequency dispersion of sway [32,33,34,35,36,37]. Nonetheless, results thus far have been contradictory, which has mainly been attributed to the wide heterogeneity of affected individuals and wide variety of study designs (for a review, see [38]). In addition, all these measures are usually acquired in laboratory experiments which often require expensive hardware and trained experts performing elaborate protocols, resources most often not available to medical practitioners, especially in developing countries [39]. Taken together, currently available objective measures thus far yield inconsistent results and are often cumbersome to assess, which is why a high-performing approach based on easily and quickly obtainable data is needed.

As in many other fields, machine learning techniques are being increasingly used to discriminate between healthy individuals and people with PD. In a recent review of 209 studies within the machine learning literature, prediction accuracies between 80 and 100% have been found using data such as voice recordings, gait patterns, hand writings and MRI imaging [40]. In terms of static balance assessments, different machine learning algorithms have been compared on various features of center of pressure (COP) sway recorded during quiet standing, leading to prediction accuracies between 64 and 83.9% [41, 42]. Some recent studies have also used deep learning approaches, where computational models are composed of multiple processing layers to learn representations of data with multiple levels of abstraction [43]. Convolutional neural networks (CNN) constitute a widely established computer vision algorithm for image classification, with an architecture somewhat similar to the ventral stream of the human visual cortical system and consist of various layers that use learnable filters for feature extraction [43, 44]. CNN approaches have been used in the context of PD based on brain imaging data like SPECT, MRI, and PET, but also successfully on physiological data like gait patterns, handwritings, and speech [45].

Given these promising applications of machine learning methods to various aspects of the disease, the aim of our study was to develop a CNN classifier trained on posturographic data based on a quick and easy assessment. For this purpose, we recorded the COP and center of mass (COM) trajectories of individuals with PD and age-matched HC during quiet standing using mobile and cost-effective devices such as a Wii balance board and a Kinect motion sensor [46,47,48] and trained a custom-built CNN to distinguish both groups based on the frequency content of their body sway. We hypothesized that a CNN trained on time–frequency spectrogram images acquired during quiet stance can reliably distinguish individuals with early to mid-stage PD from age-matched HC subjects and thus bears great potential not only for future clinical applications, but also for a better understanding of standing posture in PD.

Methods

Participants

We assessed a group of 18 individuals with idiopathic PD (age: range: [42–75]; mean ± standard deviation: 58.10 ± 8.66) in early to moderate disease stages (Hoehn and Yahr: ([1–3]; 1.94 ± 0.70) [14] with a mean disease duration of 4.8 years ([0–15]; 4.79 ± 4.71)) who were diagnosed according to the Movement Disorder Society diagnostic criteria [49]. To be included into the study, individuals with PD had to be able to walk without any assistance and not have more than one reported fall in the year prior to the study. Also, no Freezing of Gait was to occur neither in the preliminary clinical examinations nor during the measurement. All individuals with PD were measured while on their regular dose of dopaminergic medication (levodopa equivalent daily dose (LEDD): [105-1980]; 651.63 ± 529.97). Detailed information on the individuals recruited for our PD group can be found in Table 1. For the control group (healthy controls, HC), we recruited fifteen age-matched healthy adults (age: [49–69]; 59.80 ± 6.45). General exclusion criteria were any existing neurological or psychiatric (e.g., neuropathies, epilepsy, multiple sclerosis, schizophrenia, severe depression, dementia, etc.) disorders or orthopedic conditions that might affect upright stance and balance control (e.g., hip, spine, knee, etc.). Potential cognitive impairment was evaluated prior to the study based on the Montreal Cognitive Assessment with a cut-off score of 24 points [50]. All subjects had normal or corrected to normal vision.

Table 1 Participant demographics along with clinical scores of the individuals recruited for the PD group

Experimental setup

Experimental data for this study was acquired as part of two previous studies [47, 48]. Participants stood on a Wii Balance Board (WiiBB, Nintendo, Kyoto, Japan) to track their COP. Wearing no shoes, they were instructed to position their feet about shoulder width apart, about parallel on the ground. In one experimental condition, participants were to stand quietly with eyes open in a virtual 3-D environment, which consisted of a tunnel stretching in the anterior–posterior direction. During trials, they were instructed to stand relaxed with their arms hanging loosely at their sides. They had to fixate a target in the center of the far end of the tunnel to ensure their gaze remained straight ahead. In this manner, this condition simulated quiet standing in a natural environment with eyes open. One trial of measurement lasted for 30 s and was preceded and followed by resting periods where participants could relax and stretch as long as they needed. Each participant performed a total of 10 trials. To track their body motion, we used a Kinect v2 video-based motion tracking system (Microsoft, Redmond, WA, USA) which recorded the 3D-positions of 25 different ‘body joints’ as determined by an internal algorithm. The camera was located 210 cm in front of the participants and fixed at a height of 140 cm. The visual environment was presented through a head-mounted virtual reality headset (HTC Vive, HTC, New Taipei City, Taiwan). The frame rate was 90 Hz. The field of view extended over 110° in the vertical as well as in horizontal direction. Participants were secured by a harness which was attached to the ceiling. We ensured that the harness guaranteed subjects’ safety but was not providing lift during trials. For a more detailed description and depictions of the technical setup and experimental protocol, please refer to our previous work [47, 48].

Data processing, architecture, and evaluation

Out of the WiiBB sensor data, we calculated the anterior–posterior (a–p) and medio-lateral (m-l) COP trajectories for each trial. The respective trajectories of the center of mass (COM) from the Kinect data were obtained based on the interpolated center positions of relevant body segments along with their attributed mass contributions, which were taken from anthropometric tables [51]. Hence, our spatiotemporal data set consisted of time series of two postural parameters, the COP and COM, with two spatial directions per parameter, the a–p and m-l directions of body sway, respectively. Data of each parameter and direction was detrended (subtraction of the mean) and resampled to 50 Hz using a custom-written Gaussian moving average filter with a symmetric window (sigma = 1/60 s), resulting in 1500 time points per 30 s-trial. We then performed a wavelet decomposition (generalized Morse wavelets, gamma: 3; 36 voices per octave; frequency range: [0.12–15 Hz]) on all trajectory data to acquire time–frequency spectrograms for each trial. Subsequently, to obtain more data samples, the spectrograms were cut into 5 s-segments (250 time points), resulting in a total of 60 wavelet-based time–frequency spectrograms per subject (composed of 10 trials * 6 time segments) for each parameter and direction. Each spectrogram contained 2-D data (250 time points * 250 frequency bands) with one energy value associated with each time–frequency point, representing the respective frequency power. The resulting spectrograms thus resembled 250 × 250 px grayscale images with the energy values represented as pixel values (Fig. 1).

Fig. 1
figure 1

Data preprocessing. The time-course signals of the COP and COM trajectories underwent wavelet decomposition, resulting in spectrogram images with frequency power as a function of time and frequency. These spectrograms were then treated as grayscale images. Subsequently, each image was cut into six sections. The final samples constituted grayscale images with a size of 250 × 250 px

Network training using the previously acquired spectrogram images was performed for each parameter (COP, COM) and direction (a-l, m-l) separately. Since one of our aims was to establish a system that can classify new subjects, the spectrograms from each group were split into train and validation sets on a per-subject basis. Hence, all 60 spectrogram images of each participant were assigned either entirely to the train or validation set, respectively. Due to the Kinect occasionally losing tracking, 10% of the total trials in the PD group and 3% of the total trials in the HC group needed to be discarded, resulting in some participants providing less than 60 samples (PD: n = 7, HC: n = 3). To avoid biases due to unequal group sizes, for each model we trained, only 15 out of the 18 subjects with PD were randomly selected, resulting in 15 subjects in both groups. Subject data was labeled binarily regarding group. Subsequently, 11 subjects (660 samples) from each group were assigned to the training set, while the remaining 4 subjects (240 samples) were assigned to the validation set (Fig. 2).

Fig. 2
figure 2

Data pipeline and architecture. Data was split into train and validation sets on a randomized per-subject basis. For each model that we trained, data from 11 participants out of each group, consisting of the corresponding 60 sample images per participant, went into the training set. The remaining data went into the validation set. The model was then trained and evaluated for 1000 epochs. We built a CNN with three convolutional and three pooling layers, feeding into a classifier network consisting of three fully-connected layers. Network architecture was visualized using NN-SVG [52]

Once assigned to the train and validation sets, the pixel values of the spectrograms were normalized according to mean and standard deviation across all subjects. Importantly, the normalization coefficients obtained from the training set were applied to both train and validation set.

We built a custom CNN using the PyTorch framework [53]. The feature extractor network consisted of three convolutional and three pooling layers, the classifier consisted of three dense layers ending in a binary classification between PD and HC (Fig. 2). Each model was trained on full data batches over 1000 epochs with a learning rate of 0.0001 and slight regularization (weight decay = 0.001). We used an ADAM optimizer with cross-entropy-loss. A total of 250 models were trained for each parameter (COP, COM) and direction (a–p, m-l). For cross-validation purposes and to facilitate generalizability, i.e., to prevent overfitting on a specific subset of participants, the per-subject assignment to each respective train and validations set was randomized before a new model was trained, i.e., each model was trained and tested on data based on different participants. In the end, we evaluated all 250 models on average validation set performance for each parameter and direction. Evaluation metrics were predictive accuracy, sensitivity, specificity, precision and F1-score on validation set data as well as corresponding receiver operating characteristics (ROC) curves and precision-recall (PR) curves with area under the curve (AUC) [54]. We also created a baseline performance to check whether the actual network performance was based on a true difference in the spectrograms between the groups. For this purpose, we also trained 250 models with randomly assigned labels and performed the same evaluation as with the correctly labeled data sets. Network performance was compared with the baseline performance using t-tests on the validation set accuracy after 1000 epochs of training across all 250 models, respectively. We considered a p value <0.05 to reject the hypothesis that model performances between the shuffled and actual data sets came from the same distribution.

To gain insight into the decision process of the trained models, we employed an explainable AI approach utilizing Gradient-weighted Class Activation Mapping (GradCAM, [55]). GradCAMs identify the gradient information flow into the decision layer for the decoded class from each pixel of the input. The output can be visualized by heatmaps of the same size as the input image. These heatmaps indicate areas on which the model is focusing for classification, identifying which parts of the input image contribute the most to the class decision in the decision layer.

Results

Excellent classification performance in discriminating people with PD from healthy controls

Figure 3 shows randomly picked sample spectrogram images obtained through wavelet decomposition from the anterior–posterior and medio-lateral COP and COM signals. Some participants expressed a lot of energy in the lower frequency bands of their sway (bright pixels in the lower sections of the image) while higher frequencies were suppressed (dark pixels in the upper sections of the image). Others expressed more equally dispersed energy across all frequency bands. In general, similar samples could be found across all parameters and in both groups, preventing discriminability by the naked eye.

Fig. 3
figure 3

Sample grayscale spectrogram images from randomly picked participants as they are fed into the CNN. Rows represent each postural parameter we investigated. Left side shows spectrograms obtained from individuals with Parkinson’s disease (PD), right side shows spectrograms from healthy controls (HC). COP: center of pressure, COM: center of mass, m-l: medio-lateral, a–p: anterior–posterior

Table 2 displays the prediction performance of our network for the COP and COM measures in the anterior–posterior (a–p) and medio-lateral (m-l) directions, respectively, averaged over 250 training sessions with randomized train- and validation set assignments of individual subjects (see Methods). When trained on COP data, average validation accuracy, sensitivity, specificity, precision and F1-score reached about 99%, 99%, 99%, 100% and 99% for the m-l direction, respectively. Training on a–p COP data led to accuracy, sensitivity, specificity, precision and F1-score of around 90%, 85%, 89%, 92% and 87%, respectively. Also, results were more stable for the m-l direction (standard deviations of 4.5–7.9% vs. 14.8–25.5% for a–p). The receiver operating characteristics area under the curve (ROC AUC) and precision-recall area under the curve (PR AUC) reached values of 99.5% and 98.7% for the m-l direction and 92.2% and 91.4% for the a–p direction, respectively (Table 2).

Table 2 CNN performance on data from each postural parameter and corresponding direction

The network performed even better when trained on the COM data. Here, average performance scores reached about 98% accuracy, 97% sensitivity, 98% specificity, 98% precision, 98% F-1 score, 98% ROC AUC and 98% PR AUC for the a–p direction. When trained on the COM data in m-l direction, the network’s performance reached 100% accuracy, 100% sensitivity, 100% specificity, 100% precision, 100% F-1 score, 100% ROC AUC and 98% PR AUC. This demonstrated excellent predictive performance which proved to be consistent across training sessions, indicated by zero variability in almost every score across the 250 models. To ascertain that our network’s performance was based on an actual difference in the data between both groups, we created an additional data set based on the COM data in m-l direction. Here, we shuffled the labels (PD vs. HC) assigned to each sample and trained another 250 models, again each time with random assignment of participants to the train and validation set. Even though with high variability (standard deviations of 12.2–35.0%), in this case, all performance scores remained around chance level (50%) (Table 2, bottom row).

Figure 4 shows detailed performance measures for all parameters and directions. Accuracy on the training set increased monotonously over the course of 1000 epochs in each case (first row). For both the COP and the COM, performance was best when trained on m-l data. Here, training and validation accuracy quickly ramped up and plateaued at high values, most prominently for the COM data. Our network’s performance was almost identical on the validation sets, i.e., on images that it has not seen during training (Fig. 4, second row). This indicates that it performed as well on novel data as it did on data it has been trained with. The third and fourth rows of Fig. 4 show the receiver operating characteristic and precision-recall curves of representative models which performed close to the average for each parameter and direction. Our network was able to reach excellent sensitivity and specificity for almost all parameters and directions. In general, performance was better for the m-l direction vs. the a–p direction and for COM data vs. COP data.

Fig. 4
figure 4

Detailed performance on all parameters and directions. First and second row: Network performance indicated by classification accuracy evaluated on the train and validation set over 1000 epochs of training. Solid lines represent the average across 250 models with different subjects assigned to the train and validation sets in each case. Shaded areas indicate standard error. Third row: Representative ROC curves evaluated on validation data after 1000 epochs of training. Fourth row: Representative precision-recall curves evaluated on validation data after 1000 epochs of training. Rightmost column shows results from 250 models trained on medio-lateral COM data with randomized labels

The rightmost column of Fig. 4 shows performance on the COM data in m-l direction with shuffled labels. Without accurate label information, validation accuracy after 1000 epochs of training remained at chance level, confirmed by the ROC and precision-recall curves. There was a significant difference in validation accuracy across 250 models between the actual and shuffled COM m-l data sets (p < 0.0001).

Frequency content above 1 Hz was most influential to the network’s decision process

We calculated GradCAMs based on one representative model for each parameter and direction. For this purpose, we used the complete batch of validation set images and averaged them over each decoded class. The results can be seen in Fig. 5. For all parameters, pixels representing high frequency bands above 1 Hz were given the largest weights in cases where an individual with PD was classified (Fig. 5, left column). GradCAMs for classification of HC looked more varied, but also pointed towards higher frequencies (Fig. 5, right column). In general, the medio-lateral direction produced more consistent GradCAMs across models, whereas GradCAMs for the anterior–posterior sway direction were more varied. Noteworthy, weights remained consistent over time in all models.

Fig. 5
figure 5

Average gradient class activation maps (GradCAM) based on the last convolutional layer of one representative model for each parameter and direction. Left panels show average GradCAMs for individuals with PD, right panels show GradCAMs for HC. Large weights were given to pixels above 1 Hz when an individual with PD was classified. GradCAMs based on classification of HC were more varied, but also pointed towards high frequencies

Discussion

In this study, we developed a convolutional neural network classifier based on posturographic data which we obtained from individuals with PD and healthy age-matched control participants using mobile and cost-effective equipment. Our classifier was trained to distinguish between individuals of both groups based on the time–frequency content of their COP and COM trajectories during quiet stance, represented as spectrogram images. Moreover, we used GradCAMs as an explainable AI approach to investigate which sections of the spectrograms were vital for each model’s decision. We found our network to reach great classification performance in discriminating between individuals with PD and healthy controls on all postural parameters and directions, with exceptional results for medio-lateral body sway data obtained from their COM (Table 2). In general, within each parameter, all performance metrics we evaluated exhibited about equal scores, suggesting balanced classification performance across classes. In each parameter and direction, the largest variability between models occurred in the sensitivity scores, which indicated that our models were more likely to misclassify an individual with PD as healthy (false negative) than identifying a HC as PD (false positive). This variability, however, did not occur in case of the medio-lateral COM data. Here, all models exhibited 100% accuracy, sensitivity, specificity, precision and F1-score, respectively. This means, independent of which participants were selected for the train and validation sets, all samples of the validation set were correctly classified. The results from our dataset with shuffled labels confirm that our models’ classification performance stems from an actual difference between the groups. This made us confirm our general hypothesis that there are differences in the frequency content of body sway signals between both groups that are reliably detectable with a computer vision approach. Applying the GradCAM technique allowed us to obtain interpretable insight into the network’s decision process by revealing that frequency bands above 1 Hz were given the highest emphasis in all parameters and directions. However, this general trend was only consistent across models trained on the medio-lateral direction of both the COP and COM. When comparing models trained on the anterior–posterior direction, GradCAMs appeared more varied, with some models also emphasizing lower frequencies. This might be due to the explainability of GradCAMs being noisy [56] but could also stem from physiological differences in sway between the medio-lateral and anterior–posterior direction.

The fact that the frequency content of COM motion was in general more predictive of PD than that of the COP (Table 2) might stem from the different aspects of postural control these two measures are claimed to reflect [57]. The COM is generally considered the ‘controlled variable’ and its position and motion represent the total outcome of sensorimotor processing by the central nervous system (CNS) when maintaining balance [58, 59]. On the contrary, position and motion of the COP more likely reflect the musculoskeletal response or ‘effort’ of the CNS to control the position of the COM, as the COP tracks the COM and represents the forces enacted on the ground to maintain and restore upright posture [60]. However, classification performance was almost as good on the COP data, which indicates that in terms of frequencies during unperturbed quiet stance, individuals with PD show deviations in both their general ability to maintain an upright posture and in in their effort to control it.

The finding that our network performed better on data obtained from medio-lateral body sway appears plausible as PD motor symptoms are lateralized, especially in early disease stages [61, 62]. This finding indicates a larger difference in the time–frequency spectrograms between the groups and confirms various studies in the literature that used traditional sway parameters in the spatiotemporal realm. For instance, it has been found that individuals with PD show increased postural sway and stochastic activity in their medio-lateral postural sway in static balance assessments [18, 29, 63,64,65], which lead to the suggestion that lateral instability may be an important posturographic marker of functional balance impairment in PD [63, 65, 66]. This has been confirmed in a recent study using spatiotemporal analyses, where it was found that investigation of the medio-lateral direction of postural sway was best suited to differentiate between individuals with PD and HC [67]. Medio-lateral instability has also been found to better predict fall risk in PD [68]. Moreover, as all people with PD who participated in our study received levodopa at the time of testing, there is evidence that levodopa has negative effects on medio-lateral stability more so than on anterior–posterior stability, possibly increasing distinguishability for our deep learning models [22, 35].

Our GradCAMs (Fig. 5) suggest a common postural trait among the individuals with PD that manifests in higher frequency components of their postural sway during quiet stance. Biomechanically, higher frequencies have been associated with increased stiffness around the ankle joint [69], that might be explained by the increased rigidity commonly associated with PD [18, 47]. In terms of central-nervous processing of balance control, three frequency bands are usually associated with involvement of specific neuronal loops: 0–0.5 Hz for visuo-vestibular regulation, 0.5–2 Hz for cerebellar participation, and 2–20 Hz for proprioceptive participation [42, 70]. Since our models detected differences between individuals with PD and HC mostly in the frequency bands above 1 Hz, this might reflect impairments in the latter two central-nervous loops: The lower range of the most distinctive frequency bands might represent altered cerebellar activity in PD, which has been suggested to be pathological or compensatory [71, 72]. The higher range of the most distinctive frequency bands, on the other hand, might reflect impaired proprioceptive processing, which is also commonly associated with PD [4, 73, 74].

Lastly, the frequency bands revealed by our GradCAMs overlap with those of the slow resting-tremor commonly associated with PD, which manifests between 4 and 7 Hz [75]. However, pixels way above those frequencies, exceeding 10 Hz and beyond, were given similarly large weights in our network’s decisions. Moreover, we checked for tremor frequencies in the hand motion of all participants. This revealed that two of the individuals with PD exhibited a tremor, one of them in only one hand. In both cases, the tremor frequency was around 5 Hz, as reported in the literature. Thus, since only two out of 18 participants with PD exhibited a tremor, we exclude tremor as potential cause for the high gradients in the individuals with PD. This suggests the selectivity for those frequency bands and above to stem from postural motion. Another trait that is shared between all GradCAMs constitutes the weight consistency across time. On average, there seems to be no relevant temporal information in the spectrograms for the network’s decision process. On the physiological side, this means that the frequency content of postural sway during quiet stance seems to remain stable over time, for individuals with PD and healthy adults alike. In terms of classification, in our case, this means that simpler classifiers trained on 1-D frequency data might be sufficient, with the additional advantage of even larger sample sizes, since singular time points could be used.

Despite our promising results, we want to acknowledge that our study has several limitations and consider it to be of pilot nature. Even though the heterogeneity in our group of people with PD somewhat reflected the general population with early to mid-stage PD, the high variabilities in age, disease duration and medication dosage (Table 1) likely undermine the generalizability of our findings. Even though progression is often not linear, older age and longer disease durations are usually associated with more severe motor impairments and vice versa [76]. Similarly, higher dosages of dopaminergic medication likely produce more pronounced motor improvements, even though patients generally receive a medication dose that provides optimal symptom control on an individual basis, and studies on the effect of medication on static balance remain inconclusive [19, 22, 24, 25, 35, 77]. These variabilities are also reflected in the large spread of UPDRS Part III-scores in our PD group. They represent clinical assessment of motor impairments at the time of testing and in our group range from 2 (very mild) to 66 (severe). Furthermore, the main limitation of our study marks the small number of participants in the context of a deep learning approach. Even though our robust performance metrices and consistency in the GradCAMs suggest that our methods were able to capture common traits that were unique to people with PD, and we randomized data into the respective train and validation set of each model and cross-validated across many models, we cannot exclude the possibility that our models overfitted to our specific data set. Moreover, due to the smaller pool of participants, there was no variability in data from the HC group between different models. Thus, expanding our study to include a larger and more heterogeneous sample would be essential for improving the reliability and clinical applicability of our findings. In particular, it would be intriguing if our approach was able to find differences in people with de-novo PD who have not started any Parkinsonian medication yet, as this would mark a large step towards assisting clinicians in early detection and intervention, since timely neuroprotective and neuromodulatory therapies may have the potential to delay disease progression at an early stage [78, 79].

Conclusions

We trained a convolutional neural network to classify individuals with early to mid-stage PD based on the frequency content of their body sway during quiet standing and achieved excellent classification performance, suggesting that postural impairments might be reflected in specific frequency bands. Moreover, our explainable AI approach (GradCAM) might provide meaningful insight into posturographic data obtained from a PD population. As our results can be achieved with short recording times and minimal experimental effort, our study design can easily and conveniently be applied in clinical settings and bears potential to deepen understanding of postural instability in PD and to facilitate clinical evaluation of the disease. However, given the small and heterogeneous group of participants, our findings are of preliminary nature and need to be confirmed with a larger and more heterogeneous sample.

Availability of data and materials

The datasets analyzed in this study are available as open-access zenodo repository: https://doiorg.publicaciones.saludcastillayleon.es/10.5281/zenodo.13277579.

Abbreviations

PD:

Parkinson’s disease

CNN:

Convolutional neural network

HC:

Healthy controls

COP:

Center of pressure

COM:

Center of mass

MDS-UPDRS:

Movement Disorder Society Unified Parkinson’s Disease Rating Scale

DBS:

Deep brain stimulation

LEDD:

Levodopa equivalent daily dose

WiiBB:

Wii Balance Board

a–p:

Anterior–posterior

m-l:

Medio-lateral

ROC:

Receiver operating characteristics

PR:

Precision-recall

AUC:

Area under the curve

GradCAM:

Gradient-weighted class activation map

SD:

Standard deviation

CNS:

Central nervous system

References

  1. Elbaz A, Carcaillon L, Kab S, Moisan F. Epidemiology of Parkinson’s disease. Rev Neurol. 2016;172:14–26. https://doiorg.publicaciones.saludcastillayleon.es/10.1016/j.neurol.2015.09.012.

    Article  CAS  PubMed  Google Scholar 

  2. Tysnes O-B, Storstein A. Epidemiology of Parkinson’s disease. J Neural Transm. 2017;124:901–5. https://doiorg.publicaciones.saludcastillayleon.es/10.1007/s00702-017-1686-y.

    Article  PubMed  Google Scholar 

  3. Palakurthi B, Burugupally SP. Postural instability in Parkinson’s disease: a review. Brain Sci. 2019;9:239. https://doiorg.publicaciones.saludcastillayleon.es/10.3390/brainsci9090239.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Benatru I, Vaugoyeau M, Azulay JP. Postural disorders in Parkinson’s disease. Neurophysiol Clin. 2008;38:459–65. https://doiorg.publicaciones.saludcastillayleon.es/10.1016/j.neucli.2008.07.006.

    Article  CAS  PubMed  Google Scholar 

  5. Bloem BR. Postural instability in Parkinson’s disease. Clin Neurol Neurosurg. 1992;94:41–5. https://doiorg.publicaciones.saludcastillayleon.es/10.1016/0303-8467(92)90018-X.

    Article  Google Scholar 

  6. Doná F, Aquino CC, Gazzola JM, Borges V, Silva SMCA, Ganança FF, et al. Changes in postural control in patients with Parkinson’s disease: a posturographic study. Physiotherapy. 2016;102:272–9. https://doiorg.publicaciones.saludcastillayleon.es/10.1016/j.physio.2015.08.009.

    Article  PubMed  Google Scholar 

  7. Grimbergen YA, Langston JW, Roos RA, Bloem BR. Postural instability in Parkinson’s disease: the adrenergic hypothesis and the locus coeruleus. Expert Rev Neurother. 2009;9:279–90. https://doiorg.publicaciones.saludcastillayleon.es/10.1586/14737175.9.2.279.

    Article  CAS  PubMed  Google Scholar 

  8. Horak FB. Postural orientation and equilibrium: what do we need to know about neural control of balance to prevent falls? Age Ageing. 2006;35:ii7–11. https://doiorg.publicaciones.saludcastillayleon.es/10.1093/ageing/afl077.

    Article  PubMed  Google Scholar 

  9. Kim SD, Allen NE, Canning CG, Fung VSC. Postural instability in patients with Parkinson’s disease: epidemiology, pathophysiology and management. CNS Drugs. 2013;27:97–112. https://doiorg.publicaciones.saludcastillayleon.es/10.1007/s40263-012-0012-3.

    Article  PubMed  Google Scholar 

  10. Hwang S, Agada P, Grill S, Kiemel T, Jeka JJ. A central processing sensory deficit with Parkinson’s disease. Exp Brain Res. 2016;234:2369–79. https://doiorg.publicaciones.saludcastillayleon.es/10.1007/s00221-016-4642-4.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Siderowf A, McDermott M, Kieburtz K, Blindauer K, Plumb S, Shoulson I. Test–retest reliability of the unified Parkinson’s disease rating scale in patients with early Parkinson’s disease: results from a multicenter clinical trial. Mov Disord. 2002;17:758–63. https://doiorg.publicaciones.saludcastillayleon.es/10.1002/mds.10011.

    Article  PubMed  Google Scholar 

  12. Landers MR, Backlund A, Davenport J, Fortune J, Schuerman S, Altenburger P. Postural instability in idiopathic Parkinson’s disease: discriminating fallers from nonfallers based on standardized clinical measures. J Neurol Phys Ther. 2008;32:56–61. https://doiorg.publicaciones.saludcastillayleon.es/10.1097/NPT.0b013e3181761330.

    Article  PubMed  Google Scholar 

  13. Goetz CG, Tilley BC, Shaftman SR, Stebbins GT, Fahn S, Martinez-Martin P, et al. Movement disorder society-sponsored revision of the unified Parkinson’s disease rating scale (MDS-UPDRS): scale presentation and clinimetric testing results. Mov Disord. 2008;23:2129–70. https://doiorg.publicaciones.saludcastillayleon.es/10.1002/mds.22340.

    Article  PubMed  Google Scholar 

  14. Hoehn MM, Yahr MD. Parkinsonism: onset, progression, and mortality. Neurology. 1967;17:427–427. https://doiorg.publicaciones.saludcastillayleon.es/10.1212/WNL.17.5.427.

    Article  CAS  PubMed  Google Scholar 

  15. Ebersbach G, Baas H, Csoti I, Müngersdorf M, Deuschl G. Scales in Parkinson’s disease. J Neurol. 2006;253:iv32–5. https://doiorg.publicaciones.saludcastillayleon.es/10.1007/s00415-006-4008-0.

    Article  PubMed  Google Scholar 

  16. Dibble LE, Lange M. Predicting falls in individuals with Parkinson disease: a reconsideration of clinical balance measures. J Neurol Phys Ther. 2006;30:60–7. https://doiorg.publicaciones.saludcastillayleon.es/10.1097/01.NPT.0000282569.70920.dc.

    Article  PubMed  Google Scholar 

  17. Luque-Casado A, Novo-Ponte S, Sánchez-Molina JA, Sevilla-Sánchez M, Santos-Garciá D, Fernández-Del-Olmo M. Test–retest reliability of the timed up and go test in subjects with Parkinson’s disease: implications for longitudinal assessments. J Parkinsons Dis. 2021;11:2047–55. https://doiorg.publicaciones.saludcastillayleon.es/10.3233/jpd-212687.

    Article  CAS  PubMed  Google Scholar 

  18. Chastan N, Debono B, Maltête D, Weber J. Discordance between measured postural instability and absence of clinical symptoms in Parkinson’s disease patients in the early stages of the disease. Mov Disord. 2008;23:366–72. https://doiorg.publicaciones.saludcastillayleon.es/10.1002/mds.21840.

    Article  PubMed  Google Scholar 

  19. Beuter A, Hernández R, Rigal R, Modolo J, Blanchet PJ. Postural sway and effect of levodopa in early Parkinson’s disease. Can J Neurol Sci. 2008;35:65–8. https://doiorg.publicaciones.saludcastillayleon.es/10.1017/S0317167100007575.

    Article  PubMed  Google Scholar 

  20. Chen TZ, Xu GJ, Zhou GA, Wang JR, Chan P, Du YF. Postural sway in idiopathic rapid eye movement sleep behavior disorder: a potential marker of prodromal Parkinsons disease. Brain Res. 2014;1559:26–32. https://doiorg.publicaciones.saludcastillayleon.es/10.1016/j.brainres.2014.02.040.

    Article  CAS  PubMed  Google Scholar 

  21. Maetzler W, Mancini M, Liepelt-Scarfone I, Müller K, Becker C, van Lummel RC, et al. Impaired trunk stability in individuals at high risk for Parkinson’s disease. PLoS ONE. 2012;7: e32240. https://doiorg.publicaciones.saludcastillayleon.es/10.1371/journal.pone.0032240.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Curtze C, Nutt JG, Carlson-Kuhta P, Mancini M, Horak FB. Levodopa is a double-edged sword for balance and gait in people with Parkinson’s disease. Mov Disord. 2015;30:1361–70. https://doiorg.publicaciones.saludcastillayleon.es/10.1002/mds.26269.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Patel M, Nilsson MH, Rehncrona S, Tjernström F, Magnusson M, Johansson R, et al. Effects of deep brain stimulation on postural control in Parkinson’s disease. Comput Biol Med. 2020;122: 103828. https://doiorg.publicaciones.saludcastillayleon.es/10.1016/j.compbiomed.2020.103828.

    Article  PubMed  Google Scholar 

  24. Nantel J, McDonald JC, Bronte-Stewart H. Effect of medication and STN-DBS on postural control in subjects with Parkinson’s disease. Parkinsonism Relat Disord. 2012;18:285–9. https://doiorg.publicaciones.saludcastillayleon.es/10.1016/j.parkreldis.2011.11.005.

    Article  PubMed  Google Scholar 

  25. Maurer C, Mergner T, Xie J, Faist M, Pollak P, Lucking CH. Effect of chronic bilateral subthalamic nucleus (STN) stimulation on postural control in Parkinson’s disease. Brain. 2003;126:1146–63. https://doiorg.publicaciones.saludcastillayleon.es/10.1093/brain/awg100.

    Article  CAS  PubMed  Google Scholar 

  26. Allen NE, Canning CG, Almeida LRS, Bloem BR, Keus SHJ, Löfgren N, et al. Interventions for preventing falls in Parkinson’s disease. Cochrane Database Syst Rev. 2022;6:CD011574. https://doiorg.publicaciones.saludcastillayleon.es/10.1002/14651858.CD011574.pub2.

    Article  PubMed  Google Scholar 

  27. Hubble RP, Silburn PA, Naughton GA, Cole MH. Assessing stability in mild and moderate Parkinson’s disease: can clinical measures provide insight? Gait Posture. 2016;49:7–13. https://doiorg.publicaciones.saludcastillayleon.es/10.1016/j.gaitpost.2016.06.002.

    Article  PubMed  Google Scholar 

  28. Hasegawa N, Shah VV, Carlson-Kuhta P, Nutt JG, Horak FB, Mancini M. How to select balance measures sensitive to Parkinson’s disease from body-worn inertial sensors—separating the trees from the forest. Sensors. 2019;19:3320. https://doiorg.publicaciones.saludcastillayleon.es/10.3390/s19153320.

    Article  PubMed  PubMed Central  Google Scholar 

  29. Stylianou AP, McVey MA, Lyons KE, Pahwa R, Luchies CW. Postural sway in patients with mild to moderate Parkinson’s disease. Int J Neurosci. 2011;121:614–21. https://doiorg.publicaciones.saludcastillayleon.es/10.3109/00207454.2011.602807.

    Article  PubMed  Google Scholar 

  30. Horak FB, Mancini M. Objective biomarkers of balance and gait for Parkinson’s disease using body-worn sensors. Mov Disord. 2013;28:1544–51. https://doiorg.publicaciones.saludcastillayleon.es/10.1002/mds.25684.

    Article  PubMed  PubMed Central  Google Scholar 

  31. Ge W, Lueck CJ, Apthorp D, Suominen H. Which features of postural sway are effective in distinguishing Parkinson’s disease from controls? A systematic review. Brain Behav. 2021;11: e01929. https://doiorg.publicaciones.saludcastillayleon.es/10.1002/brb3.1929.

    Article  PubMed  Google Scholar 

  32. Kamieniarz A, Michalska J, Marszałek W, Stania M, Słomka KJ, Gorzkowska A, et al. Detection of postural control in early Parkinson’s disease: clinical testing vs. modulation of center of pressure. PLoS ONE. 2021;16:1–12. https://doiorg.publicaciones.saludcastillayleon.es/10.1371/journal.pone.0245353.

    Article  CAS  Google Scholar 

  33. Mancini M, Salarian A, Carlson-Kuhta P, Zampieri C, King L, Chiari L, et al. ISway: a sensitive, valid and reliable measure of postural control. J Neuroeng Rehabil. 2012;9:59. https://doiorg.publicaciones.saludcastillayleon.es/10.1186/1743-0003-9-59.

    Article  PubMed  PubMed Central  Google Scholar 

  34. Mancini M, Horak FB, Zampieri C, Carlson-Kuhta P, Nutt JG, Chiari L. Trunk accelerometry reveals postural instability in untreated Parkinson’s disease. Parkinsonism Relat Disord. 2011;17:557–62. https://doiorg.publicaciones.saludcastillayleon.es/10.1016/j.parkreldis.2011.05.010.

    Article  PubMed  PubMed Central  Google Scholar 

  35. Rocchi L, Chiari L, Horak FB. Effects of deep brain stimulation and levodopa on postural sway in Parkinson’s disease. J Neurol Neurosurg Psychiatry. 2002;73:267–74. https://doiorg.publicaciones.saludcastillayleon.es/10.1136/jnnp.73.3.267.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  36. Beretta VS, Barbieri FA, Orcioli-Silva D, dos Santos PCR, Simieli L, Vitório R, et al. Can postural control asymmetry predict falls in people with Parkinson’s disease? Mot Control. 2018;22:449–61. https://doiorg.publicaciones.saludcastillayleon.es/10.1123/mc.2017-0033.

    Article  Google Scholar 

  37. Curtze C, Nutt JG, Carlson-Kuhta P, Mancini M, Horak FB. Objective gait and balance impairments relate to balance confidence and perceived mobility in people with Parkinson disease. Phys Ther. 2016;96:1734–43. https://doiorg.publicaciones.saludcastillayleon.es/10.2522/ptj.20150662.

    Article  PubMed  PubMed Central  Google Scholar 

  38. Kamieniarz A, Michalska J, Brachman A, Pawłowski M, Słomka KJ, Juras G. A posturographic procedure assessing balance disorders in Parkinson’s disease: a systematic review. Clin Interv Aging. 2018;13:2301–16. https://doiorg.publicaciones.saludcastillayleon.es/10.2147/CIA.S180894.

    Article  PubMed  PubMed Central  Google Scholar 

  39. Dotchin C, Walker R. The management of Parkinson’s disease in sub-Saharan Africa. Expert Rev Neurother. 2012;12:661–6. https://doiorg.publicaciones.saludcastillayleon.es/10.1586/ern.12.52.

    Article  CAS  PubMed  Google Scholar 

  40. Mei J, Desrosiers C, Frasnelli J. Machine learning for the diagnosis of Parkinson’s disease: a review of literature. Front Aging Neurosci. 2021;13:1–41. https://doiorg.publicaciones.saludcastillayleon.es/10.3389/fnagi.2021.633752.

    Article  Google Scholar 

  41. Li Y, Zhang S, Odeh C. Automated classification of postural control for individuals with Parkinson’s disease using a machine learning approach: a preliminary study. J Appl Biomech. 2020;36:334–9. https://doiorg.publicaciones.saludcastillayleon.es/10.1123/JAB.2019-0400.

    Article  PubMed  Google Scholar 

  42. Fadil R, Huether A, Brunnemer R, Blaber AP, Lou JS, Tavakolian K. Early detection of Parkinson’s disease using center of pressure data and machine learning. In: Proceedings of the annual international conference of the IEEE engineering in medicine and biology society (EMBS), Mexico, 2021, p. 2433–6. https://doiorg.publicaciones.saludcastillayleon.es/10.1109/EMBC46164.2021.9630451.

  43. Lecun Y, Bengio Y, Hinton G. Deep learning. Nature. 2015;521:436–44. https://doiorg.publicaciones.saludcastillayleon.es/10.1038/nature14539.

    Article  CAS  PubMed  Google Scholar 

  44. Krizhevsky A, Sutskever I, Hinton GE. ImageNet classification with deep convolutional neural networks. Commun ACM. 2017;60:84–90. https://doiorg.publicaciones.saludcastillayleon.es/10.1145/3065386.

    Article  Google Scholar 

  45. Loh HW, Hong W, Ooi CP, Chakraborty S, Barua PD, Deo RC, et al. Application of deep learning models for automated identification of Parkinson’s disease: a review (2011–2021). Sensors. 2021;21:1–25.

    Article  Google Scholar 

  46. Engel D, Schwenk JCB, Schütz A, Morris AP, Bremmer F. Multi-segment phase coupling to oscillatory visual drive. Gait Posture. 2021;86:132–8. https://doiorg.publicaciones.saludcastillayleon.es/10.1016/j.gaitpost.2021.03.010.

    Article  PubMed  Google Scholar 

  47. Engel D, Student J, Schwenk JCB, Morris AP, Waldthaler J, Timmermann L, et al. Visual perturbation of balance suggests impaired motor control but intact visuomotor processing in Parkinson’s disease. J Neurophysiol. 2021;126:1076–89. https://doiorg.publicaciones.saludcastillayleon.es/10.1152/jn.00183.2021.

    Article  PubMed  Google Scholar 

  48. Student J, Engel D, Timmermann L, Bremmer F, Waldthaler J. Visual perturbation suggests increased effort to maintain balance in early stages of Parkinson’s to be an effect of age rather than disease. Front Hum Neurosci. 2022;16: 762380. https://doiorg.publicaciones.saludcastillayleon.es/10.3389/fnhum.2022.762380.

    Article  PubMed  PubMed Central  Google Scholar 

  49. Postuma RB, Berg D, Stern M, Poewe W, Olanow CW, Oertel W, et al. MDS clinical diagnostic criteria for Parkinson’s disease. Mov Disord. 2015;30:1591–601. https://doiorg.publicaciones.saludcastillayleon.es/10.1002/mds.26424.

    Article  PubMed  Google Scholar 

  50. Ciesielska N, Sokołowski R, Mazur E, Podhorecka M, Polak-Szabela A, Kędziora-Kornatowska K. Is the Montreal cognitive assessment (MoCA) test better suited than the mini-mental state examination (MMSE) in mild cognitive impairment (MCI) detection among people aged over 60? Meta-analysis. Psychiatr Pol. 2016;50:1039–52. https://doiorg.publicaciones.saludcastillayleon.es/10.12740/PP/45368.

    Article  PubMed  Google Scholar 

  51. Winter DA. Biomechanics and motor control of human movement. New York: Wiley; 2009.

    Book  Google Scholar 

  52. LeNail A. NN-SVG: publication-ready neural network architecture schematics. J Open Source Softw. 2019;4:747. https://doiorg.publicaciones.saludcastillayleon.es/10.21105/joss.00747.

    Article  Google Scholar 

  53. Paszke A, Gross S, Massa F, Lerer A, Bradbury J, Chanan G, et al. PyTorch: an imperative style, high-performance deep learning library. arXiv:1912.01703. 2019. https://doiorg.publicaciones.saludcastillayleon.es/10.48550/arXiv.1912.01703.

  54. Rainio O, Teuho J, Klén R. Evaluation metrics and statistical tests for machine learning. Sci Rep. 2024;14:6086. https://doiorg.publicaciones.saludcastillayleon.es/10.1038/s41598-024-56706-x.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  55. Selvaraju RR, Cogswell M, Das A, Vedantam R, Parikh D, Batra D. Grad-CAM: visual explanations from deep networks via gradient-based localization. Int J Comput Vis. 2020;128:336–59. https://doiorg.publicaciones.saludcastillayleon.es/10.1007/s11263-019-01228-7.

    Article  Google Scholar 

  56. Dhore V, Bhat A, Nerlekar V, Chavhan K, Umare A. Enhancing explainable AI: a hybrid approach combining GradCAM and LRP for CNN interpretability. arXiv:2405.12175. 2024.

  57. Richmond SB, Fling BW, Lee H, Peterson DS. The assessment of center of mass and center of pressure during quiet stance: current applications and future directions. J Biomech. 2021;123: 110485. https://doiorg.publicaciones.saludcastillayleon.es/10.1016/j.jbiomech.2021.110485.

    Article  PubMed  Google Scholar 

  58. Horak FB, Macpherson JM. Postural orientation and equilibrium. In: Comprehensive physiology. New York: Wiley; 1996. p. 255–92.

    Chapter  Google Scholar 

  59. Peterka RJ. Sensorimotor integration in human postural control. J Neurophysiol. 2002;88:1097–118. https://doiorg.publicaciones.saludcastillayleon.es/10.1152/jn.2002.88.3.1097.

    Article  CAS  PubMed  Google Scholar 

  60. Winter DA, Patla AE, Prince F, Ishac M, Gielo-Perczak K. Stiffness control of balance in quiet standing. J Neurophysiol. 1998;80:1211–21. https://doiorg.publicaciones.saludcastillayleon.es/10.1152/jn.1998.80.3.1211.

    Article  CAS  PubMed  Google Scholar 

  61. Djaldetti R, Ziv I, Melamed E. The mystery of motor asymmetry in Parkinson’s disease. Lancet Neurol. 2006;5:796–802. https://doiorg.publicaciones.saludcastillayleon.es/10.1016/S1474-4422(06)70549-X.

    Article  PubMed  Google Scholar 

  62. Riederer P, Jellinger KA, Kolber P, Hipp G, Sian-Hülsmann J, Krüger R. Lateralisation in Parkinson disease. Cell Tissue Res. 2018;373:297–312. https://doiorg.publicaciones.saludcastillayleon.es/10.1007/s00441-018-2832-z.

    Article  CAS  PubMed  Google Scholar 

  63. Mitchell SL, Collin JJ, De Luca CJ, Burrows A, Lipsitz LA. Open-loop and closed-loop postural control mechanisms in Parkinson’s disease: increased mediolateral activity during quiet standing. Neurosci Lett. 1995;197:133–6. https://doiorg.publicaciones.saludcastillayleon.es/10.1016/0304-3940(95)11924-L.

    Article  CAS  PubMed  Google Scholar 

  64. Błaszczyk JW, Orawiec R. Assessment of postural control in patients with Parkinson’s disease: sway ratio analysis. Hum Mov Sci. 2011;30:396–404. https://doiorg.publicaciones.saludcastillayleon.es/10.1016/j.humov.2010.07.017.

    Article  PubMed  Google Scholar 

  65. Błaszczyk JW, Orawiec R, Duda-Kłodowska D, Opala G. Assessment of postural instability in patients with Parkinson’s disease. Exp Brain Res. 2007;183:107–14. https://doiorg.publicaciones.saludcastillayleon.es/10.1007/s00221-007-1024-y.

    Article  PubMed  Google Scholar 

  66. Rocchi L, Chiari L, Cappello A, Horak FB. Identification of distinct characteristics of postural sway in Parkinson’s disease: a feature selection procedure based on principal component analysis. Neurosci Lett. 2006;394:140–5. https://doiorg.publicaciones.saludcastillayleon.es/10.1016/j.neulet.2005.10.020.

    Article  CAS  PubMed  Google Scholar 

  67. Sebastia-Amat S, Tortosa-Martínez J, Pueo B. The use of the static posturography to assess balance performance in a Parkinson’s disease population. Int J Environ Res Public Health. 2023;20:981. https://doiorg.publicaciones.saludcastillayleon.es/10.3390/ijerph20020981.

    Article  PubMed  PubMed Central  Google Scholar 

  68. da Conceição NR, de Sousa PN, Pereira MP, Gobbi LTB, Vitório R. Utility of center of pressure measures during obstacle crossing in prediction of fall risk in people with Parkinson’s disease. Hum Mov Sci. 2019;66:1–8. https://doiorg.publicaciones.saludcastillayleon.es/10.1016/j.humov.2019.03.010.

    Article  PubMed  Google Scholar 

  69. Warnica MJ, Weaver TB, Prentice SD, Laing AC. The influence of ankle muscle activation on postural sway during quiet stance. Gait Posture. 2014;39:1115–21. https://doiorg.publicaciones.saludcastillayleon.es/10.1016/j.gaitpost.2014.01.019.

    Article  PubMed  Google Scholar 

  70. Paillard T, Noé F. Techniques and methods for testing the postural function in healthy and pathological subjects. Biomed Res Int. 2015;2015: 891390. https://doiorg.publicaciones.saludcastillayleon.es/10.1155/2015/891390.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  71. Wu T, Hallett M. The cerebellum in Parkinson’s disease. Brain. 2013;136:696–709. https://doiorg.publicaciones.saludcastillayleon.es/10.1093/brain/aws360.

    Article  PubMed  PubMed Central  Google Scholar 

  72. Mirdamadi JL. Cerebellar role in Parkinson’s disease. J Neurophysiol. 2016;116:917–9. https://doiorg.publicaciones.saludcastillayleon.es/10.1152/jn.01132.2015.

    Article  PubMed  PubMed Central  Google Scholar 

  73. Abbruzzese G, Berardelli A. Sensorimotor integration in movement disorders. Mov Disord. 2003;18:231–40. https://doiorg.publicaciones.saludcastillayleon.es/10.1002/mds.10327.

    Article  PubMed  Google Scholar 

  74. Jacobs JV, Horak FB. Abnormal proprioceptive-motor integration contributes to hypometric postural responses of subjects with Parkinson’s disease. Neuroscience. 2006;141:999–1009. https://doiorg.publicaciones.saludcastillayleon.es/10.1016/j.neuroscience.2006.04.014.

    Article  CAS  PubMed  Google Scholar 

  75. Rivlin-Etzion M, Marmor O, Heimer G, Raz A, Nini A, Bergman H. Basal ganglia oscillations and pathophysiology of movement disorders. Curr Opin Neurobiol. 2006;16:629–37. https://doiorg.publicaciones.saludcastillayleon.es/10.1016/j.conb.2006.10.002.

    Article  CAS  PubMed  Google Scholar 

  76. Prange S, Danaila T, Laurencin C, Caire C, Metereau E, Merle H, et al. Age and time course of long-term motor and nonmotor complications in Parkinson disease. Neurology. 2019;92:E148–60. https://doiorg.publicaciones.saludcastillayleon.es/10.1212/WNL.0000000000006737.

    Article  PubMed  Google Scholar 

  77. Gago MF, Fernandes V, Ferreira J, Silva H, Rodrigues ML, Rocha L, et al. The effect of levodopa on postural stability evaluated by wearable inertial measurement units for idiopathic and vascular Parkinson’s disease. Gait Posture. 2015;41:459–64. https://doiorg.publicaciones.saludcastillayleon.es/10.1016/j.gaitpost.2014.11.008.

    Article  PubMed  Google Scholar 

  78. Holford N, Nutt JG. Disease progression, drug action and Parkinson’s disease: why time cannot be ignored. Eur J Clin Pharmacol. 2008;64:207–16. https://doiorg.publicaciones.saludcastillayleon.es/10.1007/s00228-007-0427-9.

    Article  PubMed  Google Scholar 

  79. Sarkar S, Raymick J, Imam S. Neuroprotective and therapeutic strategies against Parkinson’s disease: recent perspectives. Int J Mol Sci. 2016;17:904. https://doiorg.publicaciones.saludcastillayleon.es/10.3390/ijms17060904.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

We would like to thank all participants who were involved in this study.

Funding

Open Access funding enabled and organized by Projekt DEAL. This research was funded by Deutsche Forschungsgemeinschaft: IRTG-1901, CRC/TRR-135 (Project No. 222641018), European Union: PLATYPUS and PLACES, and Hessisches Ministerium für Wissenschaft und Kunst: The Adaptive Mind (TAM). A.P. is supported by a Marie Skłodowska-Curie Actions—H2020-MSCA-IF-2018 grant (ID: 832518, Project: MOVES).

Author information

Authors and Affiliations

Authors

Contributions

Initial draft of manuscript: DE; Data collection: DE, JS; (Pre-)processing of raw data: DE; CNN and GradCAM development and analysis: DE, KV, SG, AP; Clinical supervision: JW, LT; General supervision of the project and funding: FB. All authors read and approved the final manuscript.

Corresponding author

Correspondence to David Engel.

Ethics declarations

Ethics approval and consent to participate

All participants gave written informed consent prior to the experiment, including about the storage and processing of their data. Experimental procedures involving healthy individuals were approved by the Ethics Committee of the Psychology Department, University of Marburg. Research including individuals with PD was approved by the Ethics Committee of the Faculty of Medicine, University of Marburg (Case 77/19). All research was conducted in accordance with the Declaration of Helsinki.

Consent for publication

Not applicable.

Competing interests

The authors declare no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Engel, D., Greulich, R.S., Parola, A. et al. Sway frequencies may predict postural instability in Parkinson’s disease: a novel convolutional neural network approach. J NeuroEngineering Rehabil 22, 29 (2025). https://doiorg.publicaciones.saludcastillayleon.es/10.1186/s12984-025-01570-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doiorg.publicaciones.saludcastillayleon.es/10.1186/s12984-025-01570-7

Keywords